Breadcrumb Home Business Activities Lundbeckfonden BioCapital Lundbeckfonden BioCapital Portfolio News Share on Facebook Share on Twitter Share on LinkedIn Send link to page with mail Print page Lundbeckfonden BioCapital Portfolio News Find latest news about a company and their developments This is press releases sent out by the companies. Questions and comments should be send to the company directly. Search terms Spero Therapeutics 13 January 2020 Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners Everest Medicines and the Department of Defense Acacia Pharma 13 January 2020 Acacia Pharma Group PLC – Issue of Equity on Share Subscription and Licensing agreement With Cosmo Pharmaceuticals Acacia Pharma 10 January 2020 Acacia Pharma Group PLC enters into strategic in-licensing, investment and loan transaction with Cosmo Pharmaceuticals N.V. Auro Biosciences 7 January 2020 Aura Biosciences Appoints George Golumbeski, Ph.D., as Chairman of the Board of Directors BONESUPPORT 6 January 2020 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Bonesupport 19 December 2019 BONESUPPORT appoints Kristina Ingvar to Executive Vice President Quality Management & Regulatory Affairs Bonesupport 9 December 2019 BONESUPPORTTM CERTiFy STUDY ON CERAMENT ® BONE VOID FILLER NOW PUBLISHED IN THE JOURNAL OF BONE AND JOINT SURGERY Veloxis 25 November 2019 Veloxis to Host Conference Call Following Asahi Kasei Group’s Announcement of a Recommended Conditional Voluntary Public Offer for Veloxis BONESUPPORT 13 November 2019 BONESUPPORT appoints Fergus MacLeod as General Manager and Executive Vice President Commercial Operations EUROW Sanifit 12 November 2019 Sanifit to host webcast: Phase 2b CaLIPSO trial of SNF472 Sanifit 12 November 2019 Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation Bonesupport 7 November 2019 BONESUPPORT HOLDING AB (publ) – Publishes Q3 2019 Interim report Acacia Pharma 31 October 2019 Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Bonesupport 31 October 2019 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Bonesupport 30 October 2019 BONESUPPORT HOLDING AB (publ) – Q3 2019 Interim Report – invitation to conference call and webcast Sanifit 30 October 2019 Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis Top line data to be presented at 2019 Scientific Sessions of American Heart Associa Acacia Pharma 22 October 2019 Issue of Equity on Exercise of Options/Vesting of Performance Share Awards AFYX Therapeutics 10 October 2019 AFYX Therapeutics Presents Results from Rivelin Clinical Proof of Concept Study in Patients with Vulvar Lichen Sclerosus at the 2019 European Academy of Dermatology and Venereology Congress Bonesupport 30 September 2019 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Acacia Pharma 26 September 2019 Acacia Pharma Group PLC – Acacia Pharma Announces New BARHEMSYS® PDUFA Target Date of 26 February 2020 Sanifit 23 September 2019 Sanifit named as one of 2019’s “Fierce 15” biotechnology companies by FierceBiotech Bonesupport 19 September 2019 BONESUPPORT HOLDING AB presents health economic evidence Acacia Pharma 17 September 2019 Acacia Pharma Group plc – Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Amplyx Pharmaceuticals 17 September 2019 Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients Amplyx Pharmaceuticals 17 September 2019 Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Amplyx Pharmaceuticals 10 September 2019 FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications Acacia Pharma 5 September 2019 Acacia Pharma Group plc – Interim Results for the Six Months ended 30 June 2019 Bonesupport 2 September 2019 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Acacia Pharma 16 August 2019 Acacia Pharma Group PLC – Acacia Pharma Group plc – Issue of Equity on Exercise of Options Acacia Pharma 12 August 2019 Acacia Pharma Group PLC – Acacia Pharma Group plc: Notice of Interim Results Pagination First page « Første Previous page ‹‹ … Page 5 Page 6 Current page 7 Page 8 Page 9 … Next page ›› Last page Sidste » Business Activities Lundbeckfonden BioCapital About Lundbeckfonden BioCapital Lundbeckfonden BioCapital News Lundbeckfonden BioCapital Portfolio Lundbeckfonden BioCapital Portfolio News Strategic Investments Invest
